Ramaiah Medical College, Bangalore.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
The infection caused due to novel coronavirus 2 can cause wide spectrum of disease from asymptomatic mild disease to life threatening disease. The widespread inflammation is most likely the cause of the adverse outcomes. There are numerous markers of the inflammation which are used to identify the severity and prognosis of the disease. Neutrophil lymphocyte ratio (NLR) is one such marker which is easily available and feasible in all the hospital settings. This study intended to evaluate the NLR as a marker of disease severity and prognosis, in those with Covid-19.
This was a retrospective study to determine the utility of NLR as a marker of severity and prognosis among patients with Covid disease. Medical records of 60 patients admitted with mild to moderate Covid-19 disease were reviewed and relevant data was retrieved. The NLR at admission and 72 hours later was noted. High resolution computerised tomography was done and computerised tomography severity score (CT-SS) was calculated. The outcomes of these patients were noted.
Mean NLR at admission in mild disease was 5.6 and in moderate disease was 9.2. This difference was found to be statistically significant. It was also seen that NLR had a positive co-relation with CT severity score, duration of hospital stay, C- reactive protein (CRP) and D-dimer.
The study shows that neutrophil- lymphocyte ratio is a good indicator of disease severity and has prognostic significance in Covid-19. There is a positive correlation with high-resolution computed tomography (HRCT) chest score and other markers of inflammation among patients with Covid-19. Serial monitoring of NLR can be utilised as a surrogate to HRCT chest to determine disease severity whenever the latter is not available. This can ensure early intervention and help prevent mortality.
本研究旨在评估 NLR 作为 COVID-19 患者疾病严重程度和预后的标志物。
这是一项回顾性研究,旨在确定 NLR 作为 COVID 疾病严重程度和预后标志物的效用。回顾性分析了 60 例轻中度 COVID-19 住院患者的病历,提取了相关数据。记录入院时和 72 小时后的 NLR,进行高分辨率计算机断层扫描(HRCT),计算 CT 严重程度评分(CT-SS)。观察这些患者的结局。
轻度疾病的平均 NLR 为 5.6,中度疾病的平均 NLR 为 9.2。差异有统计学意义。还发现 NLR 与 CT 严重程度评分、住院时间、C 反应蛋白(CRP)和 D-二聚体呈正相关。
该研究表明,中性粒细胞-淋巴细胞比值是疾病严重程度的良好指标,对 COVID-19 具有预后意义。与 COVID-19 患者的高分辨率 CT(HRCT)胸部评分和其他炎症标志物呈正相关。在 HRCT 胸部检查不可用时,可定期监测 NLR 作为 HRCT 胸部的替代指标,以确定疾病严重程度。这可以确保早期干预,有助于降低死亡率。